公司資料
PepGen 股價、新聞與催化劑
- 股票代碼:
- PEPG
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
3.14 USD (+3.46%)
收盤價
最後更新: 2026年8月21日
100M USD
市值
股價為何變動
As of Aug 21, 2026, PEPG closed up 3.46% at $3.14. No new same-company headline was identified in the current news window.
公司概覽
Oligonucleotide Delivery Company
PepGen develops Enhanced Delivery Oligonucleotides intended to transport therapeutic oligonucleotides into skeletal muscle.
PGN-EDODM1
PGN-EDODM1 is designed to correct RNA splicing in myotonic dystrophy type 1 by releasing pathogenic RNA and restoring downstream protein expression.
FREEDOM2
The FREEDOM2 study is evaluating multiple ascending doses, with early cohorts assessing safety, splice correction, and functional biomarkers.
未來催化劑
- Data from the fully enrolled 10 mg/kg FREEDOM2 cohort are expected in the second half of 2026.
- Data from the 12.5 mg/kg cohort are anticipated in 2027.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。